RET and medullary thyroid gland carcinoma: Most MTC cases present point mutations of RET proto-oncogene that can occur sporadically or as hereditary germline events in the multiple endocrine neoplasia syndromes (MEN2A and MEN2B) or in familial medullary thyroid cancer (FMTC) (25).